Ignite Creation Date:
2024-05-06 @ 4:00 PM
Last Modification Date:
2024-10-26 @ 2:01 PM
Study NCT ID:
NCT04831658
Status:
UNKNOWN
Last Update Posted:
2022-06-02
First Post:
2021-04-02
Brief Title:
A Prospective Clinical Study of BTK Inhibitor PD-1 and Formustine in the First-line Treatment of Primary Central Nervous System Lymphoma
Sponsor:
Mingzhi Zhang
Organization:
Zhengzhou University
Organization Data
Organization:
Zhengzhou University
Class:
OTHER
Study ID:
hnslblzlzx20210303
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Mingzhi Zhang
Lead Sponsor Class:
OTHER
Responsible Party:
Mingzhi Zhang
Responsible Party Title:
the director of oncology department of the first affiliated hospital
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Zhengzhou University
Old Name:
None
Old Organization:
None